BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19878078)

  • 1. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study.
    Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O
    Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
    Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
    Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions.
    Seebach C; Henrich D; Tewksbury R; Wilhelm K; Marzi I
    Calcif Tissue Int; 2007 Apr; 80(4):294-300. PubMed ID: 17431529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
    Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
    Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Punturieri M; Moretti S; Dabusti M; Spanedda R; Castoldi G
    Bone Marrow Transplant; 2003 Dec; 32(12):1165-73. PubMed ID: 14647271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery.
    del Cañizo MC; Lopez N; Vazquez L; Fernandez ME; Ana B; Caballero MD; Amigo ML; Mateos MV; Gutierrez N; San Migue JF
    Haematologica; 1999 Jun; 84(6):511-6. PubMed ID: 10366794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of chemotherapy on hematopoietic microenvironment and effect of autologous bone marrow stromal cell infusion on the recovery of hematopoiesis after chemotherapy].
    Liu J; Ji S; Zhou L; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):341-3. PubMed ID: 11877093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony forming unit assays for MSCs.
    Pochampally R
    Methods Mol Biol; 2008; 449():83-91. PubMed ID: 18370085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis.
    Koller MR; Manchel I; Palsson BO
    Stem Cells; 1997; 15(4):305-13. PubMed ID: 9253115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
    Hu Y; Ma L; Ma GJ; Jiang XY; Zhao CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases.
    Dimitriou H; Linardakis E; Martimianaki G; Stiakaki E; Perdikogianni CH; Charbord P; Kalmanti M
    Cytotherapy; 2008; 10(2):125-33. PubMed ID: 18368591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.